# AIDA 2000 Guidelines

> **NCT01064570** · PHASE2 · UNKNOWN · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 600 (estimated)

## Conditions studied

- Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** all-trans retinoic acid (ATRA)

## Key facts

- **NCT ID:** NCT01064570
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01064570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01064570, "AIDA 2000 Guidelines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01064570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*